1Suppliers
1Customers
0Debt Items
16Related Chains

Source-Backed Evidence Depth

Satellos Bioscience Inc. (MSLE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

2Total relationships
0Distinct source URLs
0High confidence
0.720Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Satellos Bioscience Inc. Suppliers

TickerNameConfidenceEvidence
KROS Keros Therapeutics, Inc. 72% Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirement…

Satellos Bioscience Inc. Customers

TickerNameConfidenceEvidence
KROS Keros Therapeutics, Inc. 72% Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirement…

Satellos Bioscience Inc. Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Satellos Bioscience Inc..

Satellos Bioscience Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Satellos Bioscience Inc..

Satellos Bioscience Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Satellos Bioscience Inc..

Satellos Bioscience Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
EWTX Edgewise Therapeutics, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
SRRK Scholar Rock Holding Corporation 100.00 2
SNYNF Sanofi 100.00 2
TAK Takeda Pharmaceutical Company Limited 100.00 2
RNAM Avidity Biosciences, Inc. 100.00 2
IBIO iBio, Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
SRPT Sarepta Therapeutics, Inc. 100.00 2
KROS Keros Therapeutics, Inc. 36.29 1 ['customer', 'supplier']
GOSS Gossamer Bio, Inc. 14.78 2
PTCT PTC Therapeutics, Inc. 14.78 2
SLDB Solid Biosciences Inc. 14.78 2
🔐
MSLE
Unlock MSLE Supply Chain Data
Verified relationships include:
KROSKeros Therapeutics, Inc.Supplier72%
KROSKeros Therapeutics, Inc.Customer72%
Subscribe — View plans →